[Cyclosporin A, a Peptide Metabolite from Trichoderma polysporum (Link ex Pers.) Rifai, with a remarkable immunosuppressive activity]
about
History of clinical transplantationInhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agentEvaluating bionanoparticle infused fungal metabolites as a novel antimicrobial agentThe cyclic cystine ladder of theta-defensins as a stable, bifunctional scaffold: A proof-of-concept study using the integrin-binding RGD motifTranscription factor Xpp1 is a switch between primary and secondary fungal metabolismConstraining cyclic peptides to mimic protein structure motifs.Spontaneous N --> O acyl shift in the [M + H](+) ions of [MeBmt1]-cyclosporins in an ion trap.Multiple N-methylation of MT-II backbone amide bonds leads to melanocortin receptor subtype hMC1R selectivity: pharmacological and conformational studies.Low-dose cyclosporine treatment for sight-threatening uveitis: efficacy, toxicity, and tolerance.Immunophilins: switched on protein binding domains?The chemistry of signal transduction.Identification of Quorum-Sensing Inhibitors Disrupting Signaling between Rgg and Short Hydrophobic Peptides in Streptococci.cis-Peptide Bonds: A Key for Intestinal Permeability of Peptides? .Novel Trichoderma polysporum Strain for the Biocontrol of Pseudogymnoascus destructans, the Fungal Etiologic Agent of Bat White Nose Syndrome.A fascinating journey into history: exploration of the world of isonitriles en route to complex amidesDeletion of Ac-NMePhe(1) from [NMePhe(1) ]arodyn under acidic conditions, part 1: effects of cleavage conditions and N-terminal functionalityDendritic cells initiate immune control of epstein-barr virus transformation of B lymphocytes in vitro.V101L of human formyl peptide receptor 1 (FPR1) increases receptor affinity and augments the antagonism mediated by cyclosporins.A new and clinically relevant murine model of solid-organ transplant aspergillosis.Correlation of naturally occurring HIV-1 resistance to DEB025 with capsid amino acid polymorphismsThe use of cyclosporin A and prednisone in cadaver kidney transplantationBeyond cyclosporine A: conformation-dependent passive membrane permeabilities of cyclic peptide natural products.Probing the biology of natural products: molecular editing by diverted total synthesis.Peptides and proteins as a continuing exciting source of inspiration for peptidomimetics.Calcineurin inhibitors and immunosuppression - a tale of two isoforms.Hartmann Stahelin (1925-2011) and the contested history of cyclosporin A.Strategies for mining fungal natural products.Natural product and natural product derived drugs in clinical trials.Endophytes as producers of peptides: an overview about the recently discovered peptides from endophytic microbes.Chemical ecology of fungi.Structure-Based Design of Inhibitors of Protein-Protein Interactions: Mimicking Peptide Binding Epitopes.Calcineurin Inhibitors: Pharmacologic Mechanisms Impacting Both Insulin Resistance and Insulin Secretion Leading to Glucose Dysregulation and Diabetes Mellitus.Facile synthesis of a fluorescent cyclosporin a analogue to study cyclophilin 40 and cyclophilin 18 ligands.Cyclosporine: structure, pharmacokinetics, and therapeutic drug monitoring.Total synthesis of cyclosporine: access to N-methylated peptides via isonitrile coupling reactions.Immune suppression with cyclosporin A-optimism and caution.Diltiazem co treatment with cyclosporine for induction of disease remission in sight-threatening non-infectious intraocular inflammation.Cyclosporin A: a new advance in transplantation.Cyclosporin A: in vivo and in vitro suppression of rat T-lymphocyte function.[The structure of cyclosporin c (author's transl)]
P2860
Q24596303-5F2BB4AC-0816-40EF-89A6-9B55392C668EQ24656023-FDB1C13F-D9DE-4306-8849-31F121A3E532Q26700039-D3A99DEE-36B2-4C0C-B97F-A0BAB193E106Q27688055-B114DF99-B2BC-4E00-825B-549C9FBD3E01Q28817915-34243D2D-DCE3-483F-9CEE-4333A141C5B8Q30367509-189C6762-D69B-4EFA-AA56-BDC29580686EQ30702635-23C77CC6-68B8-4B00-89C4-BD8A62E8FEEBQ33585575-749F045E-542C-42E3-8BDA-581DAEFAE89BQ33737959-B575CB3F-96EB-4D4D-92B5-4EC082A37A32Q34073758-A485F32C-6667-4EF9-88EC-F0695AC8646CQ34800255-B2F019BC-9474-4E87-99C6-073F4D677C5CQ35620197-C70323CC-74C9-4B77-8A5B-3EB650D409A9Q35764128-F933EFB6-E745-4678-9F70-FB9E3BDE8904Q35824028-34FB76B7-073B-4ED9-BBEE-7C55898A2B4DQ36131535-88CF1AA2-3B46-45CD-8D77-7008C49C6874Q36143025-9C0DAF06-E5D4-40CA-A446-34ADCB316D1BQ36371518-ADD12C56-9646-4081-A555-50A61399BE46Q36783290-8A26EE4D-E79A-43AB-A7F4-C17B7637D2AEQ36790931-BBC16387-A8D3-4153-A568-73AF83D447E8Q36993953-382F0AA1-0579-4357-8D89-41B1B4B3394AQ37305573-0092FDE1-84E2-466D-A73B-FA998E618DBBQ37532708-86E805A9-923A-4736-A504-CD8D4AA9578DQ37809500-883EE00E-1F43-43F5-BD6B-792FE7F16D15Q37900558-75DB43C1-B016-4B4E-8211-72A0A533C1ECQ38027011-7083F900-BBCE-4D50-B744-699B84240B02Q38075058-EB11F21C-C0FB-4D40-9341-5D72398019B5Q38154539-1FE014B9-ABE5-4F50-B774-FF97DFEFA68BQ38247457-C4CC7B6A-358C-4AE0-9435-4360A3A563A7Q38247822-7E74B2FA-2046-483F-A8BD-422C55E1AA2EQ38514165-58272216-8EA1-424F-A07F-BC3FA3680DEFQ38539666-063F4F6A-C666-4A45-B96B-020D622FAF75Q38996428-30B4268C-8B0F-4E8F-B804-861C87A1F582Q39155902-30D2B3D0-5349-4079-8C2F-F8D65C576A9BQ39689835-2B56D2CF-019C-47DF-AA02-A1938CAF8857Q39781344-2033C5AD-2C25-4640-8274-C79211B77DD8Q40317133-EBB63932-781B-4599-AF6D-5E5301418CD5Q40413542-D144DB09-6870-48CB-91BA-5F22FB70FB81Q40615260-52A3D004-1832-4230-91AC-03EB3D6C17CDQ40709188-31E5B1CA-F1A2-4A06-85A0-D09BF971E6DCQ41955872-FA6DF7AD-553D-4EEF-A1C5-C628AF9CCDBD
P2860
[Cyclosporin A, a Peptide Metabolite from Trichoderma polysporum (Link ex Pers.) Rifai, with a remarkable immunosuppressive activity]
description
1976 nî lūn-bûn
@nan
1976 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1976 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
name
[Cyclosporin A, a Peptide Meta ...... le immunosuppressive activity]
@ast
[Cyclosporin A, a Peptide Meta ...... le immunosuppressive activity]
@en
[Cyclosporin A, a Peptide Meta ...... le immunosuppressive activity]
@nl
type
label
[Cyclosporin A, a Peptide Meta ...... le immunosuppressive activity]
@ast
[Cyclosporin A, a Peptide Meta ...... le immunosuppressive activity]
@en
[Cyclosporin A, a Peptide Meta ...... le immunosuppressive activity]
@nl
prefLabel
[Cyclosporin A, a Peptide Meta ...... le immunosuppressive activity]
@ast
[Cyclosporin A, a Peptide Meta ...... le immunosuppressive activity]
@en
[Cyclosporin A, a Peptide Meta ...... le immunosuppressive activity]
@nl
P2093
P356
P1476
[Cyclosporin A, a Peptide Meta ...... le immunosuppressive activity]
@en
P2093
Huguenin R
Quiquerez C
von Wartburg A
P2860
P304
P356
10.1002/HLCA.19760590412
P577
1976-01-01T00:00:00Z